Last reviewed · How we verify
The Usefulness of Assessing Heart Rate Variability in Patients With Acute Myocardial Infarction: From Primary Angioplasty to Secondary Long-term Prevention - a Single Centre, Prospective, Observational Cohort Study (HeaRt-V-AMI)
Aims * heart rate variability (HRV) assessment in patients with acute myocardial infarction who undergo primary percutaneous coronary intervention (PCI); * measurement of HRV using a device approved for medical use in Europe; * assessment of the correlation between HRV and short- and long-term adverse cardiovascular events (composite of all-cause mortality and major adverse cardiovascular events - MACE; ventricular arrhythmias; hospital admissions for heart failure; left ventricular systolic and diastolic disfunction; MACE in special subgroups of patients - elderly, diabetes mellitus, chronic kidney disease) in patients treated by primary PCI for acute myocardial infarction; * creating a registry of HRV parameters measured in a contemporary cohort of patients with acute myocardial infarction.
Details
| Lead sponsor | Grigore T. Popa University of Medicine and Pharmacy |
|---|---|
| Status | UNKNOWN |
| Enrolment | 200 |
| Start date | 2021-11 |
| Completion | 2024-10 |
Conditions
- Myocardial Infarction
- Autonomic Dysfunction
Interventions
- Heart rate variability measurement
- Percutaneous coronary intervention
Primary outcomes
- Composite of all-cause mortality and major adverse cardiovascular events (MACE) — in-hospital, 1 month and 1 year
MACE will be defined as cardiac mortality, fatal and non-fatal myocardial infarction, unplanned target vessel revascularization and stroke)
Countries
Romania